Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$15.81 - $18.96 $295,647 - $354,552
-18,700 Reduced 13.79%
116,900 $2.11 Million
Q2 2024

Aug 14, 2024

SELL
$12.78 - $17.4 $3.18 Million - $4.33 Million
-248,900 Reduced 64.73%
135,600 $2.2 Million
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $440,671 - $595,959
41,300 Added 12.03%
384,500 $5.43 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $876,147 - $1.15 Million
107,900 Added 45.86%
343,200 $3.58 Million
Q3 2023

Nov 15, 2023

BUY
$7.48 - $10.7 $1.76 Million - $2.52 Million
235,300 New
235,300 $2.4 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.